中文
 

Follow us 

Hot Topic
Market News
Events & Promo
Career Tips
Education News
Health & Life
Excelra Recognized as a Leader in Everest Group's Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026
PRNewswire

Excelra Recognized as a Leader in Everest Group's Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026

Publish date: 04 Nov 2026

Follow us

Stay updated on the job market

Popular Articles

【AI 衝擊打工仔】最新調查:逾半港人憂AI令退休前景更難預測!「飯碗不保」恐打破傳統退養規劃
【AI 衝擊打工仔】最新調查:逾半港人憂AI令退休前景更難預測!「飯碗不保」恐打破傳統退養規劃
【薪酬趨勢調查】本港僱員今年平均加薪 2.3%!預測明年升至 3.1%,增幅仍遜大灣區內地城市
【薪酬趨勢調查】本港僱員今年平均加薪 2.3%!預測明年升至 3.1%,增幅仍遜大灣區內地城市
【鐵飯碗神話幻滅?】護理畢業即失業!寄成百封 CV 零回音,香港護士正面臨大洗牌
【鐵飯碗神話幻滅?】護理畢業即失業!寄成百封 CV 零回音,香港護士正面臨大洗牌
【方大資訊日2026】首日吸引逾5,000人入場!聖方濟各大學拆解熱門課程入學攻略,應科大實務教學成焦點
【方大資訊日2026】首日吸引逾5,000人入場!聖方濟各大學拆解熱門課程入學攻略,應科大實務教學成焦點
【求職變負債】應徵「在家工作」兼職文員竟要借貸代購名牌?40歲港婦一個半月痛失近200萬
【求職變負債】應徵「在家工作」兼職文員竟要借貸代購名牌?40歲港婦一個半月痛失近200萬

A science-first approach to data and AI places Excelra among the 9 Leaders out of 34 providers assessed

HYDERABAD, India, Nov. 4, 2026 /PRNewswire/ -- Excelra, a global life sciences data and informatics company, has been positioned as a Leader in Everest Group's Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026 among 34 service providers assessed on market impact, and vision and capability through a comprehensive RFI process including client references.

Excelra Recognized as a Leader in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026
Excelra Recognized as a Leader in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026

Everest Group's assessment credits Excelra's combination of curated data, scientific AI, and domain expertise. GOSTAR®, Excelra's flagship product with 37M bioactivity data points, is built to be AI/ML ready. Excelra's scientific AI solutions are grounded in high-quality scientific data and purpose-built for life sciences R&D. Recent M&As have expanded onshore scientific consulting talent and proximity to global clients. Excelra's robust partner ecosystem spans leading cloud providers, lab informatics, and technology platforms.

"Pharmaceutical enterprises are prioritizing partners that combine deep scientific and functional expertise with strong data, AI, and platform capabilities," says Durga Ambati, VP at Everest Group. "Excelra stands out through its proprietary scientific datasets, including GOSTAR, which supports SAR intelligence for AI drug discovery, and verticalized scientific AI solutions that span across multimodal data analytics, scientific knowledge retrieval, and regulatory intelligence. These strengths have positioned Excelra as a Leader in our Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026."

"Science comes first." says Anandbir Brar, CEO of Excelra. "It is a conviction we have never compromised, and this recognition validates that belief. In pharma R&D, scientific depth now carries as much weight as scale. As AI moves into the core of R&D, it's critical that partners understand both science and technology. I am grateful to our clients for trusting us with their most important work, and proud of the teams whose expertise made this possible."

To read Everest Group's assessment of Excelra, visit https://www.excelra.com/publications/everest-group-peak-matrix-2026/#download-the-report.

About Excelra

Excelra engineers trust into AI-driven R&D, combining AI-ready data and platforms, connected lab informatics, and multi-omics expertise to turn R&D complexity into decisions you can defend. Science led. Data driven. Outcomes focused. www.excelra.com.

About Everest Group

Everest Group is a leading research firm helping business leaders make confident decisions. It guides clients through today's market challenges and strengthens their strategies by applying contextualized problem-solving to their unique situations. www.everestgrp.com.

Excelra Recognized as a Leader in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026
Excelra Recognized as a Leader in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026

Follow us

Stay updated on the job market

Popular Articles

【AI 衝擊打工仔】最新調查:逾半港人憂AI令退休前景更難預測!「飯碗不保」恐打破傳統退養規劃
【AI 衝擊打工仔】最新調查:逾半港人憂AI令退休前景更難預測!「飯碗不保」恐打破傳統退養規劃
【薪酬趨勢調查】本港僱員今年平均加薪 2.3%!預測明年升至 3.1%,增幅仍遜大灣區內地城市
【薪酬趨勢調查】本港僱員今年平均加薪 2.3%!預測明年升至 3.1%,增幅仍遜大灣區內地城市
【鐵飯碗神話幻滅?】護理畢業即失業!寄成百封 CV 零回音,香港護士正面臨大洗牌
【鐵飯碗神話幻滅?】護理畢業即失業!寄成百封 CV 零回音,香港護士正面臨大洗牌
【方大資訊日2026】首日吸引逾5,000人入場!聖方濟各大學拆解熱門課程入學攻略,應科大實務教學成焦點
【方大資訊日2026】首日吸引逾5,000人入場!聖方濟各大學拆解熱門課程入學攻略,應科大實務教學成焦點
【求職變負債】應徵「在家工作」兼職文員竟要借貸代購名牌?40歲港婦一個半月痛失近200萬
【求職變負債】應徵「在家工作」兼職文員竟要借貸代購名牌?40歲港婦一個半月痛失近200萬

Hottest Tags

#AI衝擊打工仔
#人工智能退休規劃
#香港打工仔退休
#職場淘汰
#生成式AI
#退休前景
#強積金MPF
#中年失業風險
#技能轉型
#職場焦慮
#薪酬趨勢調查
#香港加薪幅度

Contact Us
Notice
Back to Top
We use cookies to enhance your experience on our website. Please read and confirm your agreement to our Privacy Policy and Terms and Conditions before continue to browse our website. Read and Agreed